• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to Thomas Van den Broeck, R. Jeffrey Karnes, and Steven Joniau's Letter to the Editor re: Amar U. Kishan, Talha Shaikh, Pin-Chieh Wang, et al. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol 2017;71:766-73.

作者信息

Kishan Amar U, Steinberg Michael L, Kupelian Patrick A, King Christopher R

机构信息

Department of Radiation Oncology, University of California, Los Angeles, CA, USA.

Department of Radiation Oncology, University of California, Los Angeles, CA, USA.

出版信息

Eur Urol. 2017 Nov;72(5):e123-e124. doi: 10.1016/j.eururo.2017.01.017. Epub 2017 Jan 19.

DOI:10.1016/j.eururo.2017.01.017
PMID:28111115
Abstract
摘要

相似文献

1
Reply to Thomas Van den Broeck, R. Jeffrey Karnes, and Steven Joniau's Letter to the Editor re: Amar U. Kishan, Talha Shaikh, Pin-Chieh Wang, et al. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol 2017;71:766-73.对托马斯·范登·布罗克、R.杰弗里·卡恩斯和史蒂文·乔尼奥的致编辑信的回复，信的内容涉及阿马尔·U.基尚、塔尔哈·谢赫、平杰·王等人的《接受放疗或根治性前列腺切除术的 Gleason 评分 9 - 10 前列腺腺癌患者的临床结局：多机构比较分析》。《欧洲泌尿外科杂志》2017 年；71:766 - 73。
Eur Urol. 2017 Nov;72(5):e123-e124. doi: 10.1016/j.eururo.2017.01.017. Epub 2017 Jan 19.
2
Re: Amar U. Kishan, Talha Shaikh, Pin-Chieh Wang, et al. Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis. Eur Urol 2017;71:766-73.回复：阿玛尔·U·基尚、塔尔哈·谢赫、Pin-Chieh Wang等人。接受放疗或根治性前列腺切除术治疗的 Gleason 评分 9 - 10 前列腺腺癌患者的临床结果：多机构比较分析。《欧洲泌尿外科杂志》2017 年；71:766 - 73。
Eur Urol. 2017 Nov;72(5):e121-e122. doi: 10.1016/j.eururo.2017.01.018. Epub 2017 Jan 17.
3
Reply to Amar U. Kishan, William Hall, and Daniel Spratt's Letter to the Editor re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552-5 Comparing Apples to Oranges: A Self-fulfilling Prophecy?对阿玛尔·U·基尚、威廉·霍尔和丹尼尔·斯普拉特致编辑的信的回复，信的主题为：塞巴斯蒂安·伯格、亚历山大·P·科尔、玛丽克·J·克林普霍夫等人。高危局限性前列腺癌患者行根治性前列腺切除术与外照射放疗加近距离放疗的比较疗效。《欧洲泌尿外科杂志》2019年；75卷：552 - 5页 拿苹果与橙子作比较：一种自我实现的预言？
Eur Urol. 2019 May;75(5):e135-e136. doi: 10.1016/j.eururo.2019.01.017. Epub 2019 Jan 19.
4
Reply to Pim J. van Leeuwen and Henk G. van der Poel's Letter to the Editor re: Karim A. Touijer, Robert J. Karnes, Niccolo Passoni, et al. Survival Outcomes of Men with Lymph Node-positive Prostate Cancer After Radical Prostatectomy: A Comparative Analysis of Different Postoperative Management Strategies. Eur Urol 2018;73:890-6.对皮姆·J·范·李文和亨克·G·范·德·波尔致编辑的信的回复，信的内容涉及卡里姆·A·图耶尔、罗伯特·J·卡恩斯、尼科洛·帕索尼等人的《根治性前列腺切除术后淋巴结阳性前列腺癌男性的生存结果：不同术后管理策略的比较分析》。《欧洲泌尿外科杂志》2018年；73卷：890 - 896页。
Eur Urol. 2018 Jul;74(1):e18-e19. doi: 10.1016/j.eururo.2018.04.002.
5
Reply to Francesco Montorsi, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, et al. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. Eur Urol 2020;77:614-27.对弗朗切斯科·蒙托西、安德里亚·萨洛尼亚和阿尔贝托·布里甘蒂致编辑的信的回复，信的主题为：丽莎·莫里、马库斯·G·坎伯巴奇、托马斯·范登布罗克等人。高危局限性和局部进展性前列腺癌主要治疗方法的获益与风险：一项国际多学科系统评价。《欧洲泌尿外科杂志》2020年；77卷：614 - 27页。
Eur Urol. 2020 Nov;78(5):e193-e194. doi: 10.1016/j.eururo.2020.07.041. Epub 2020 Aug 21.
6
Re: Alessandro Morlacco, John C. Cheville, Laureano J. Rangel, Derek J. Gearman, R. Jeffrey Karnes. Adverse Disease Features in Gleason Score 3 + 4 "Favorable Intermediate-risk" Prostate Cancer: Implications for Active Surveillance. Eur Urol 2017;72:442-7.回复：亚历山德罗·莫拉科、约翰·C·切维尔、劳雷亚诺·J·兰热尔、德里克·J·吉尔曼、R·杰弗里·卡恩斯。 Gleason评分3+4“有利的中危”前列腺癌的不良疾病特征：对主动监测的影响。《欧洲泌尿外科杂志》2017年；72卷：442 - 447页
Eur Urol. 2017 Nov;72(5):e125. doi: 10.1016/j.eururo.2017.01.040. Epub 2017 Feb 3.
7
Reply to Alberto Briganti, Giorgio Gandaglia, Markus Graefen, Steven Joniau, R. Jeffrey Karnes, and Francesco Montorsi's Letter to the Editor re: Jean F.P. Lestingi, Giuliano B. Guglielmetti, Quoc-Dien Trinh, et al. Extended Versus Limited Pelvic Lymph Node Dissection During Radical Prostatectomy for Intermediate- and High-risk Prostate Cancer: Early Oncological Outcomes from a Randomized Phase 3 Trial. Eur Urol 2021;79:595-604. Time for a Change? Clinically Meaningful Reasons Why We Will Continue Performing Extended Pelvic Lymph Node Dissection in Selected Patients with Prostate Cancer.
Eur Urol. 2021 Jun;79(6):e184-e185. doi: 10.1016/j.eururo.2021.02.038. Epub 2021 Mar 6.
8
Re: Clinical Outcomes for Patients with Gleason Score 9-10 Prostate Adenocarcinoma Treated With Radiotherapy or Radical Prostatectomy: A Multi-institutional Comparative Analysis.关于：采用放疗或根治性前列腺切除术治疗的 Gleason 评分 9 - 10 前列腺腺癌患者的临床结局：一项多机构比较分析。
Eur Urol. 2016 Dec;70(6):1079-1080. doi: 10.1016/j.eururo.2016.08.030. Epub 2016 Aug 25.
9
Reply to Xueliang Zhou and Xinwei Han's Letter to the Editor re: Thomas Van den Broeck, Roderick C.N. van den Bergh, Nicolas Arfi, et al. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review. Eur Urol 2019;75:967-87.回复周雪亮和韩新伟致编辑的信，内容涉及：托马斯·范登布罗克、罗德里克·C·N·范登伯格、尼古拉斯·阿尔菲等人。前列腺癌根治性治疗后生化复发的预后价值：一项系统评价。《欧洲泌尿外科杂志》2019年；75卷：967 - 87页。
Eur Urol. 2019 Jul;76(1):e16. doi: 10.1016/j.eururo.2019.03.027. Epub 2019 Apr 6.
10
Re: Amar U. Kishan, Rahul D. Tendulkar, Phuoc T. Tran, et al. Optimizing the Timing of Salvage Postprostatectomy Radiotherapy and the Use of Concurrent Hormonal Therapy for Prostate Adenocarcinoma. Eur Urol Oncol. In press: Primum Non Nocere: Adding Hormone Therapy to Early Salvage Radiotherapy Makes the Physician Feel Better, But Does It Help the Patient?回复：阿玛尔·U·基尚、拉胡尔·D·滕杜尔卡、福克·T·陈等。优化前列腺切除术后挽救性放疗的时机以及前列腺腺癌同步激素治疗的应用。《欧洲泌尿外科肿瘤学》。即将发表：首要的是不伤害：在早期挽救性放疗中添加激素治疗让医生感觉更好，但对患者有帮助吗？
Eur Urol Oncol. 2018 Sep;1(4):323-324. doi: 10.1016/j.euo.2018.06.016. Epub 2018 Jul 17.

引用本文的文献

1
With New Technology Comes Great Responsibility: Prostate-Specific Membrane Antigen Imaging in Recurrent Prostate Cancer.新技术带来重大责任：复发性前列腺癌中的前列腺特异性膜抗原成像
J Clin Oncol. 2022 Sep 10;40(26):3015-3019. doi: 10.1200/JCO.22.00493. Epub 2022 Jun 3.